Bria-PROS+ moves into Phase 1/2a testing with FDA clearance in prostate cancer
FDA clearance allows Bria-PROS+ to enter Phase 1/2a prostate cancer testing. Read how the off-the-shelf cellular immunotherapy works.
Pharma & Biotech